Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)
Authors:
- John A. BlessingJBJohn A. Blessing
- Neil RosensheinNRNeil Rosenshein
- Guy PhotopulosGPGuy Photopulos
- Philip J. DiSaiaPDPhilip J. DiSaia
- 1 August 1989
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 161 (2) , 309-312
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1986
- DECHLOROETHYLATION OF IFOSFAMIDE AND NEUROTOXICITYThe Lancet, 1986
- Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.Journal of Clinical Oncology, 1986
- A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1985
- Malignant mixed müllerian tumors of the uterusCancer, 1984
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamideGynecologic Oncology, 1983
- Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tractGynecologic Oncology, 1982